Advance Your Cell Therapy With Innovative CRISPR & mRNA-LNP Tools

Next-generation cell therapies are reshaping therapeutics by precisely engineering living cells for both ex vivo and in vivo applications. Cutting-edge tools—including Cas enzymes (Cas9, Cas12a), base and prime editors, and synthetic guide RNAs—enhance specificity, persistence, and potency beyond traditional methods. This webinar will spotlight GenScript’s advanced CRISPR toolkit and integrated RNA/LNP delivery platform, combining optimized RNA formats with targeted delivery strategies. Participants will learn how these innovations accelerate CAR-T engineering, enhance in vivo delivery, and streamline the path from design to clinical application. 

Learning Objectives: 

1. Unlock the Power of Precision – Explore GenScript’s next-gen CRISPR Nuclease and OmniGuide RNA platforms for safe, efficient, and highly specific genome edits. 

2. Understand Advanced RNA Formats – Learn how circRNA, StabiRNA, and novel capping strategies extend RNA stability, enhance expression, and reduce immune activation.

3. Leverage RNA & LNP Synergy – Discover how optimized RNA formats combined with lipid nanoparticles, enhanced with ligand or antibody decoration, enable efficient, targeted delivery to T cells and other tissues, streamlining workflows and improving therapeutic outcomes.